Leveraging the power of RNA & AI for diagnostics
ALCEDIAG Leveraging the power of RNA and AI for diagnostics


Blood test to differentiate unipolar depression from bipolar disorder


Cell-based solutions to mimic drug impact on RNA editing


Integrated platform from RNA / DNA sequencing to machine learning and AI

Innovative Diagnostic Company

​ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics, primarily for mental health. These offerings are based upon the company’s distinctive expertise in epigenetics, RNA, and Artificial Intelligence, complemented by neurosciences and psychiatry.

ALCEDIAG’s unique approach is protected by seven patent families and supported by a global network of Key Opinion Leaders, who serve both as advocate for and early adopt of ALCEDIAG’s solutions.